LEADER 04166nam 22005895 450 001 9910863160003321 005 20251113173949.0 010 $a3-030-57254-4 024 7 $a10.1007/978-3-030-57254-9 035 $a(CKB)4100000011508743 035 $a(DE-He213)978-3-030-57254-9 035 $a(MiAaPQ)EBC6381218 035 $a(PPN)257359842 035 $a(MiAaPQ)EBC29093067 035 $a(EXLCZ)994100000011508743 100 $a20201014d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Biology and Advances in Treatment /$fedited by Phuc Van Pham 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (XI, 174 p. 1 illus.) 225 1 $aInnovations in Cancer Research and Regenerative Medicine,$x2662-3293 ;$v1292 311 08$a3-030-57253-6 327 $a1. The BRCA1 and BRCA2 genes in early onset breast cancer patients -- 2. Anti-cancer effect of Xao tam phan Paramignya trimera methanol root extract on human breast cancer cell line MCF-7 in 3D model -- 3. A novel nonsense mutation c.374C>G in CYP21A2 gene of a Vietnamese patient with congenital adrenal hyperplasia -- 4. Variation of Mitochondrial DNA HV1 AND HV2 of the Vietnamese Population -- 5. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and its Cytotoxicity Effects in Tamoxifen-resistant Breast Cancer Cells -- 6. Adipose-derived mesenchymal stem cells promote growth and migration of lung adenocarcinoma cancer cells -- 7. Predictive potential of PD-L1, TYMS and DCC expressions in treatment outcome of colorectal carcinoma -- 8. Clinical trials with cytokine-induced killer cells and CAR-T cell transplantation for non-small cell lung cancer treatment -- 9. Isopanduratin A isolated from Boesenbergia pandurata reduces HepG2 hepatocellular carcinoma cell proliferation in both monolayer and three-dimensional cultures -- 10. Hopea Odorata extract can efficiently kill breast cancer cells and cancer stem like cells in three-dimensional culture more than in monolayer cell culture -- 11. Selective cytotoxicity of some plant extracts against hepatocellular carcinoma cells but not mesenchymal stem cells: A pilot screening. 330 $aThis new series, based on a bi-annual conference and its topics, represents a major contribution to the emerging science of cancer research and regenerative medicine. Each volume brings together some of the most pre-eminent scientists working on cancer biology, cancer treatment, cancer diagnosis, cancer prevention and regenerative medicine to share information on currently ongoing work which will help shape future therapies. These volumes are invaluable resources not only for already active researchers or clinicians but also for those entering these fields, plus those in industry. Cancer Biology and Advances in Treatment is a proceedings volume which reflects papers presented at the 3rd bi-annual Innovations in Regenerative Medicine and Cancer Research conference; taken with its companion volume Tissue Engineering and Regenerative Medicine and Stem Cells: Biology and Engineering it provides a complete overview of the papers from that meeting of international experts. . 410 0$aInnovations in Cancer Research and Regenerative Medicine,$x2662-3293 ;$v1292 606 $aStem cells 606 $aRegenerative medicine 606 $aCancer 606 $aStem Cell Biology 606 $aRegenerative Medicine and Tissue Engineering 606 $aCancer Biology 615 0$aStem cells. 615 0$aRegenerative medicine. 615 0$aCancer. 615 14$aStem Cell Biology. 615 24$aRegenerative Medicine and Tissue Engineering. 615 24$aCancer Biology. 676 $a616.99406 700 $aPham$b Phuc Van$01061906 702 $aPham$b Phuc Van 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910863160003321 996 $aCancer Biology and Advances in Treatment$94464973 997 $aUNINA